CZ282759B6 - Derivát isatinoximu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje - Google Patents
Derivát isatinoximu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje Download PDFInfo
- Publication number
- CZ282759B6 CZ282759B6 CZ94395A CZ39594A CZ282759B6 CZ 282759 B6 CZ282759 B6 CZ 282759B6 CZ 94395 A CZ94395 A CZ 94395A CZ 39594 A CZ39594 A CZ 39594A CZ 282759 B6 CZ282759 B6 CZ 282759B6
- Authority
- CZ
- Czechia
- Prior art keywords
- isatinoxime
- group
- formula
- branched
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75116591A | 1991-08-28 | 1991-08-28 | |
| US83185192A | 1992-02-05 | 1992-02-05 | |
| PCT/EP1992/001999 WO1993005043A1 (en) | 1991-08-28 | 1992-08-27 | Novel isatinoxime derivatives, their preparation and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CZ39594A3 CZ39594A3 (en) | 1994-11-16 |
| CZ282759B6 true CZ282759B6 (cs) | 1997-09-17 |
Family
ID=27115380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ94395A CZ282759B6 (cs) | 1991-08-28 | 1992-08-27 | Derivát isatinoximu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0529636B1 (enExample) |
| JP (1) | JP3170584B2 (enExample) |
| KR (1) | KR100277481B1 (enExample) |
| AT (1) | ATE181552T1 (enExample) |
| AU (1) | AU655672B2 (enExample) |
| CA (1) | CA2076948C (enExample) |
| CZ (1) | CZ282759B6 (enExample) |
| DE (1) | DE69229461T2 (enExample) |
| DK (1) | DK0529636T3 (enExample) |
| FI (1) | FI107156B (enExample) |
| GE (1) | GEP20002329B (enExample) |
| HU (2) | HUT70753A (enExample) |
| MX (1) | MX9204914A (enExample) |
| NO (1) | NO301117B1 (enExample) |
| PL (1) | PL170920B1 (enExample) |
| RU (1) | RU2114827C1 (enExample) |
| SK (1) | SK280578B6 (enExample) |
| WO (1) | WO1993005043A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08502483A (ja) | 1992-10-13 | 1996-03-19 | ワーナー−ランバート・コンパニー | 新規なキノキサリンジオン誘導体、それらの製造および使用 |
| US5843945A (en) * | 1993-05-13 | 1998-12-01 | Neurosearch A/S | AMPA antagonists and a method of treatment |
| FI954965L (fi) * | 1993-05-13 | 1995-11-10 | Neurosearch As | AMPA-antagonisteja ja hoitomenetelmä, jossa niitä käytetään |
| DK81593D0 (da) * | 1993-07-07 | 1993-07-07 | Neurosearch As | Nye isatinoximderivater, deres fremstilling og anvendelse |
| EP0781285B1 (en) * | 1994-09-14 | 2000-01-12 | Neurosearch A/S | Fused indole and quinoxaline derivatives, their preparation and use as glutamate antagonists |
| CA2199613C (en) * | 1994-09-14 | 2000-02-29 | Peter Moldt | Indole-2,3-dione-3-oxime derivatives, their preparation and use |
| UA54403C2 (uk) * | 1996-10-01 | 2003-03-17 | Н'Юросерч А/С | Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму |
| FR2768624B1 (fr) * | 1997-09-25 | 1999-11-12 | Oreal | Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue |
| DE60041399D1 (de) | 1999-05-19 | 2009-03-05 | Painceptor Pharma Corp | Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen |
| EP1736468A3 (en) | 2000-01-24 | 2007-01-03 | NeuroSearch A/S | Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation |
| WO2004039372A1 (en) | 2002-10-29 | 2004-05-13 | Sungkyunkwan University | Medicament component of berberine for the use of prevention and treatment of psycological dependence on and analgesic tolerance to morphine |
| EP1957486A4 (en) | 2005-11-23 | 2009-11-11 | Painceptor Pharma Corp | COMPOSITIONS AND METHODS FOR MODULATION OF IONIC CHANNELS |
| WO2014095675A1 (en) | 2012-12-19 | 2014-06-26 | Bayer Cropscience Ag | Difluoromethyl-nicotinic-indanyl carboxamides as fungicides |
| US9815768B2 (en) * | 2014-02-28 | 2017-11-14 | Sumitomo Chemical Company, Limited | Method for producing 2-(halogenomethyl)-3-methylnitrobenzene |
| HUE055651T2 (hu) | 2016-03-17 | 2021-12-28 | Fmc Corp | Eljárás S-enantiomer konvertálására racém formájává |
| CN112266368B (zh) * | 2017-11-15 | 2024-03-19 | 中山光禾医疗科技有限公司 | 光交联水凝胶材料的制备、原料、产品及应用 |
| CN108912127B (zh) * | 2018-08-27 | 2019-12-10 | 青岛农业大学 | 一种基于靛红骨架的苯并[b,e]氮杂卓化合物及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE69677B1 (en) * | 1989-12-11 | 1996-10-02 | Neurosearch As | Isatine derivatives their preparation and use |
-
1992
- 1992-08-26 MX MX9204914A patent/MX9204914A/es not_active IP Right Cessation
- 1992-08-26 CA CA002076948A patent/CA2076948C/en not_active Expired - Fee Related
- 1992-08-27 KR KR1019940700676A patent/KR100277481B1/ko not_active Expired - Fee Related
- 1992-08-27 AU AU24820/92A patent/AU655672B2/en not_active Ceased
- 1992-08-27 JP JP50493393A patent/JP3170584B2/ja not_active Expired - Fee Related
- 1992-08-27 CZ CZ94395A patent/CZ282759B6/cs not_active IP Right Cessation
- 1992-08-27 SK SK238-94A patent/SK280578B6/sk unknown
- 1992-08-27 PL PL92302584A patent/PL170920B1/pl unknown
- 1992-08-27 GE GEAP19922683A patent/GEP20002329B/en unknown
- 1992-08-27 EP EP92114654A patent/EP0529636B1/en not_active Expired - Lifetime
- 1992-08-27 WO PCT/EP1992/001999 patent/WO1993005043A1/en not_active Ceased
- 1992-08-27 RU RU94019425/04A patent/RU2114827C1/ru not_active IP Right Cessation
- 1992-08-27 AT AT92114654T patent/ATE181552T1/de not_active IP Right Cessation
- 1992-08-27 DE DE69229461T patent/DE69229461T2/de not_active Expired - Lifetime
- 1992-08-27 HU HU9400595A patent/HUT70753A/hu unknown
- 1992-08-27 DK DK92114654T patent/DK0529636T3/da active
-
1994
- 1994-02-25 FI FI940889A patent/FI107156B/fi active
- 1994-02-25 NO NO940676A patent/NO301117B1/no unknown
-
1995
- 1995-06-21 HU HU95P/P00323P patent/HU211632A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993005043A1 (en) | 1993-03-18 |
| AU655672B2 (en) | 1995-01-05 |
| FI107156B (fi) | 2001-06-15 |
| EP0529636A1 (en) | 1993-03-03 |
| FI940889A7 (fi) | 1994-02-25 |
| CZ39594A3 (en) | 1994-11-16 |
| NO940676D0 (no) | 1994-02-25 |
| SK23894A3 (en) | 1994-12-07 |
| NO301117B1 (no) | 1997-09-15 |
| MX9204914A (es) | 1993-07-01 |
| GEP20002329B (en) | 2000-12-25 |
| HU9400595D0 (en) | 1994-05-30 |
| DE69229461T2 (de) | 1999-10-21 |
| SK280578B6 (sk) | 2000-04-10 |
| JPH06510056A (ja) | 1994-11-10 |
| NO940676L (enExample) | 1994-04-27 |
| DK0529636T3 (da) | 1999-12-13 |
| RU2114827C1 (ru) | 1998-07-10 |
| CA2076948C (en) | 2002-04-16 |
| HUT70753A (en) | 1995-10-30 |
| FI940889A0 (fi) | 1994-02-25 |
| DE69229461D1 (de) | 1999-07-29 |
| HU211632A9 (en) | 1995-12-28 |
| AU2482092A (en) | 1993-04-05 |
| ATE181552T1 (de) | 1999-07-15 |
| JP3170584B2 (ja) | 2001-05-28 |
| PL170920B1 (pl) | 1997-02-28 |
| CA2076948A1 (en) | 1993-03-01 |
| EP0529636B1 (en) | 1999-06-23 |
| KR100277481B1 (ko) | 2001-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ282759B6 (cs) | Derivát isatinoximu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje | |
| EP0587473B1 (fr) | Dérivés condensés de la pyridine comme inhibiteurs de l'effet des radicaux libres | |
| EP0503349B1 (en) | Hydrazone derivatives, their preparation and use | |
| US4382030A (en) | 2-Acylaminomethyl-1,4-benzodiazepine derivatives and their salts, pharmaceutical compositions thereof and process for their preparation | |
| EP0059391A1 (de) | Imidazodiazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DK164704B (da) | 3,6-disubstituerede triazolo-oe3,4-aaa-ftalazinderivater, fremgangsmaade til fremstilling deraf, udgangsforbindelse til anvendelse i fremgangsmaaden samt anvendelse af og farmaceutisk praeparat indeholdende forbindelserne | |
| Hussenether et al. | Clozapine derived 2, 3-dihydro-1H-1, 4-and 1, 5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing | |
| Walser et al. | Pentacyclic triazolodiazepines as PAF‐antagonists | |
| JP3010558B2 (ja) | 新規の１，７‐融合１ｈ‐インドール‐２‐カルボン酸‐ｎ‐（１，４‐ベンゾジアゼピン‐３‐イル）‐アミド、その製法及びこれを含有するコレシストキニン拮抗作用薬剤 | |
| JPH0311067A (ja) | 興奮性アミノ酸拮抗剤 | |
| JPH0227358B2 (enExample) | ||
| DE60218646T2 (de) | N-biphenylcarbonyl- und n-phenylpyridylcarbonyl substituierte bi- und tricyclische azepine und diazepine als vasopressin-agonisten | |
| US5436250A (en) | Isatineoxime derivatives, their preparation and use | |
| US5242918A (en) | Isatinoxime derivatives, their preparation and use | |
| DE3587556T2 (de) | 2-Substituierte Aminomethyl-1,4-benzodiazepine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
| US20020198191A1 (en) | Cyclohexylphenyl vasopressin agonists | |
| CS226743B2 (en) | Method of preparing new 1,4,9,10-tetrahydropyrazolo (4,3-e)pyrido (3,2-b) l,4)diazepin-10-ones | |
| CA2165618C (fr) | Nouveaux ethers d'oximes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| JP3781698B2 (ja) | 新規ピリミジン−４−オン化合物、その調製方法、およびそれらを含む医薬組成物 | |
| JP2001512124A (ja) | 新規な２，３−ベンゾジアゼピン誘導体 | |
| WO1993008166A1 (en) | Benzo-isoquinoline derivatives and analogs and their use in therapeutics | |
| CN114671829B (zh) | 以茚酮和二苯并氮杂卓为母核的杂二联体及其盐酸盐、其制备方法和用途 | |
| HUP0100751A2 (hu) | Új aril-vagy heteroaril-kinolinilfoszfonsav-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
| AT395155B (de) | Verfahren zur herstellung von neuen imidazo(1,5-a)(1,4)diazepinverbindungen | |
| LU84775A1 (fr) | Nouveaux derives cycloaliphatiques condenses de pyrido(1,2-a)pyrimidines substituees |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF00 | In force as of 2000-06-30 in czech republic | ||
| MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20030827 |